Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,173,752
  • Shares Outstanding, K 170,300
  • Annual Sales, $ 16,310 M
  • Annual Income, $ 1,360 M
  • EBIT $ 3,326 M
  • EBITDA $ 4,493 M
  • 60-Month Beta 1.37
  • Price/Sales 1.91
  • Price/Cash Flow 10.21
  • Price/Book 4.69

Options Overview Details

View History
  • Implied Volatility 40.38% (+4.51%)
  • Historical Volatility 58.65%
  • IV Percentile 69%
  • IV Rank 35.14%
  • IV High 66.53% on 04/10/25
  • IV Low 26.22% on 11/26/25
  • Expected Move (DTE 8) 50.92 (31.41%)
  • Put/Call Vol Ratio 8.36
  • Today's Volume 1,132
  • Volume Avg (30-Day) 1,583
  • Put/Call OI Ratio 1.14
  • Today's Open Interest 15,908
  • Open Int (30-Day) 7,410
  • Expected Range 111.20 to 213.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.55
  • Number of Estimates 7
  • High Estimate 2.69
  • Low Estimate 2.47
  • Prior Year 2.37
  • Growth Rate Est. (year over year) +7.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
160.00 +3.85%
on 02/12/26
244.82 -32.13%
on 01/13/26
-74.71 (-31.02%)
since 01/12/26
3-Month
160.00 +3.85%
on 02/12/26
247.04 -32.74%
on 01/09/26
-54.73 (-24.78%)
since 11/12/25
52-Week
134.65 +23.40%
on 05/23/25
247.04 -32.74%
on 01/09/26
-31.67 (-16.01%)
since 02/12/25

Most Recent Stories

More News
The Top 5 Analyst Questions From IQVIA’s Q4 Earnings Call

The Top 5 Analyst Questions From IQVIA’s Q4 Earnings Call

IQV : 165.70 (-6.48%)
IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and the Duke Clinical Research...

IQV : 165.70 (-6.48%)
IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis

IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis

IQV : 165.70 (-6.48%)
Stocks Settle Lower as Tech and Crypto are Routed

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -1.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.38%. March...

MSTR : 124.73 (-1.06%)
GOOGL : 311.87 (+0.29%)
ARES : 137.19 (-0.14%)
AAPL : 270.40 (-1.85%)
GLXY : 20.47 (+0.34%)
DDOG : 130.10 (+2.18%)
ALGN : 197.85 (+0.17%)
$IUXX : 25,187.41 (-0.05%)
COIN : 146.31 (-4.50%)
ZNH26 : 112-155 (+0.18%)
MSFT : 400.79 (-0.89%)
TSLA : 427.50 (-0.18%)
IQVIA (IQV) Stock Trades Down, Here Is Why

IQVIA (IQV) Stock Trades Down, Here Is Why

IQV : 165.70 (-6.48%)
Stocks Retreat as Tech Stocks Fall and the US Labor Market Weakens

The S&P 500 Index ($SPX ) (SPY ) today is down -1.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.49%. March E-mini S&P futures...

MSTR : 124.73 (-1.06%)
GOOGL : 311.87 (+0.29%)
ARES : 137.19 (-0.14%)
AAPL : 270.40 (-1.85%)
GLXY : 20.47 (+0.34%)
ALGN : 197.85 (+0.17%)
$IUXX : 25,187.41 (-0.05%)
COIN : 146.31 (-4.50%)
ZNH26 : 112-155 (+0.18%)
MSFT : 400.79 (-0.89%)
TSLA : 427.50 (-0.18%)
ESH26 : 6,963.25 (+0.04%)
Stocks Extend Slump as Tech Rout Deepens

The S&P 500 Index ($SPX ) (SPY ) today is down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.40%. March E-mini S&P futures...

MSTR : 124.73 (-1.06%)
GOOGL : 311.87 (+0.29%)
ARES : 137.19 (-0.14%)
AAPL : 270.40 (-1.85%)
ADI : 342.43 (+1.61%)
GLXY : 20.47 (+0.34%)
TXN : 228.27 (+0.75%)
ALGN : 197.85 (+0.17%)
$IUXX : 25,187.41 (-0.05%)
COIN : 146.31 (-4.50%)
ZNH26 : 112-155 (+0.18%)
MSFT : 400.79 (-0.89%)
IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates

IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates

IQV : 165.70 (-6.48%)
IQVIA: Q4 Earnings Snapshot

IQVIA: Q4 Earnings Snapshot

IQV : 165.70 (-6.48%)
IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Revenue of $4,364 million for the fourth quarter, $16,310 million for the full year GAAP Net Income of $514 million for the fourth quarter, $1,360 million...

IQV : 165.70 (-6.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in...

See More

Key Turning Points

3rd Resistance Point 193.35
2nd Resistance Point 189.17
1st Resistance Point 183.18
Last Price 165.70
1st Support Level 173.01
2nd Support Level 168.83
3rd Support Level 162.84

See More

52-Week High 247.04
Fibonacci 61.8% 204.11
Fibonacci 50% 190.85
Fibonacci 38.2% 177.58
Last Price 165.70
52-Week Low 134.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar